Delivery Order SPE2DR25D1104-SPE2DR26FK819
- Not listed
- The Defense Logistics Agency awarded a $4,002.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 mL pen injections on December 18, 2025, with completion targeted for December 19, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This is a non-set-aside competitive award, reflecting the...
- The Defense Logistics Agency awarded a $1,205.46 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Zepbound 2.5 mg/0.5 ml pen injections. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries no set-aside designation and is scheduled for completion by December 24, 2025,...
- The Defense Logistics Agency awarded a $1,107.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on December 9, 2025, with completion scheduled for December 10, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be performed at...
- The Defense Logistics Agency awarded a $68,632.20 delivery order to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen injections on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $31,730.30 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Zepbound 10 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 30, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $26,418.80 delivery order to AmerisourceBergen Drug Corp for Zepbound 12.5 mg/0.5 mL pen injections on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,492.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on December 24, 2025, with an ultimate completion date of December 26, 2025. This competitive, firm fixed-price contract was placed with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,822.28 to AmerisourceBergen Drug Corp for ZEPBOUND 12.5 mg/0.5 mL pen injections on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,578.39 to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections on September 15, 2025, with completion scheduled for September 16, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $3,214.64 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK819Delivery Order
The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contracts with the Defense Logistics Agency reflects its capability to meet competitive procurement requirements for military and veteran healthcare systems. This particular delivery order for Zepbound, a diabetes medication, aligns with AmerisourceBergen's demonstrated expertise in supplying specialty pharmaceuticals to support the Defense Health Agency and other federal healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.9k | 12/30/25 |